학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 63건 | 목록 1~20
Academic Journal
Clin Cancer Res
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Dipòsit Digital de la UB
Universidad de Barcelona
CLINICAL CANCER RESEARCH
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Academic Journal
Pla H; Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia, 17007 Girona, Spain.; Precision Oncology Group (OncoGIR-Pro), 17007 Girona, Spain.; Biomedical Research Institute (IDIBGI-CERCA), 17190 Salt, Spain.; Fullana B; Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Esteve A; Badalona Applied Research Group in Oncology (B-ARGO), Translational Program in Cancer Research (CARE), Germans Trias i Pujol Research Institute (IGTP), 08916 Badalona, Spain.; Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia, 08916 Badalona, Spain.; Fort-Culillas R; Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia, 17007 Girona, Spain.; Precision Oncology Group (OncoGIR-Pro), 17007 Girona, Spain.; Biomedical Research Institute (IDIBGI-CERCA), 17190 Salt, Spain.; Ferrando-Díez A; Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia, 08916 Badalona, Spain.; Fernández-Ortega A; Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Pous A; Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia, 08916 Badalona, Spain.; Stradella A; Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Villanueva-Vázquez R; Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Cirauqui B; Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia, 08916 Badalona, Spain.; Falo C; Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Martínez-Pérez E; Breast Cancer Unit, Department of Radiation Oncology, Institut Català d'Oncologia, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Molina G; Breast Cancer Unit, Department of Radiation Oncology, Institut Català d'Oncologia, 08916 Badalona, Spain.; Del Barco S; Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia, 17007 Girona, Spain.; Precision Oncology Group (OncoGIR-Pro), 17007 Girona, Spain.; Biomedical Research Institute (IDIBGI-CERCA), 17190 Salt, Spain.; Eraso A; Breast Cancer Unit, Department of Radiation Oncology, Institut Català d'Oncologia, 17007 Girona, Spain.; Margelí M; Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia, 08916 Badalona, Spain.; Viñas G; Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia, 17007 Girona, Spain.; Precision Oncology Group (OncoGIR-Pro), 17007 Girona, Spain.; Biomedical Research Institute (IDIBGI-CERCA), 17190 Salt, Spain.; Gil-Gil M; Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Petriz L; Oncology Results Office, Directorate of Clinical Strategy, Research and Clinical Results, Institut Català d'Oncologia, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Pernas S; Breast Cancer Unit, Department of Medical Oncology, Institut Català d'Oncologia, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Academic Journal
Siu LL; Princess Margaret Cancer Centre, Toronto, Canada.; Postel-Vinay S; Institut Gustave Roussy, Villejuif, France.; Villanueva-Vázquez R; Institut Català d'Oncologia, Early Drug Development Unit, Medical Oncology Department, ICO-Hospitalet, Barcelona, Spain.; de Velasco G; Hospital Universitario 12 de Octubre, Medical Oncology, Madrid, Spain.; Castanon Alvarez E; Clínica Universidad de Navarra, Medical Oncology, Madrid, Spain.; Kyriakopoulos CE; Department of Medicine, University of Wisconsin, Madison, Wisconsin.; Johnson M; Lung Cancer Research, Sarah Cannon Research Institute at Tennessee Oncology, Nashville, Tennessee.; Ouali K; Drug Development Department, Institut Gustave Roussy, Villejuif, France.; McMorn S; AstraZeneca, Cambridge, United Kingdom.; Angell HK; AstraZeneca, Cambridge, United Kingdom.; Ng F; AstraZeneca, Cambridge, United Kingdom.; Saran S; AstraZeneca, Cambridge, United Kingdom.; Bayat M; AstraZeneca, Cambridge, United Kingdom.; Collins T; AstraZeneca, Cambridge, United Kingdom.; Roy A; AstraZeneca, Gaithersburg, Maryland.; Lambert AW; AstraZeneca, Waltham, Massachusetts.; Cho S; AstraZeneca, Gaithersburg, Maryland.; Miller N; AstraZeneca, Cambridge, United Kingdom.; Petruzzelli M; AstraZeneca, Cambridge, United Kingdom.; Stone J; AstraZeneca, Cambridge, United Kingdom.; Massard C; DITEP, Institut Gustave Roussy, Villejuif, France.; Faculty of Medicine, Paris Saclay University, Paris, France.; Molecular Radiotherapy Unit 1030, National Institute of Health and Medical Research (INSERM), Paris, France.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Chandarlapaty S; Memorial Sloan Kettering Cancer Center, New York, New York.; Dickler MN; Memorial Sloan Kettering Cancer Center, New York, New York.; Perez Fidalgo JA; Hospital Clinico Universitario of Valencia, Biomedical Research Institute INCLIVA, CIBERONC, Valencia, Spain.; Villanueva-Vázquez R; Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain.; Giltnane J; Genentech, Inc., South San Francisco, California.; Gates M; Genentech, Inc., South San Francisco, California.; Chang CW; Genentech, Inc., South San Francisco, California.; Cheeti S; Genentech, Inc., South San Francisco, California.; Fredrickson J; Genentech, Inc., South San Francisco, California.; Wang X; Genentech, Inc., South San Francisco, California.; Collier A; Genentech, Inc., South San Francisco, California.; Moore HM; Genentech, Inc., South San Francisco, California.; Metcalfe C; Genentech, Inc., South San Francisco, California.; Lauchle J; Genentech, Inc., South San Francisco, California.; Humke EW; Genentech, Inc., South San Francisco, California.; Bardia A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Villanueva-Vázquez, R.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어